Literature DB >> 18455306

A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population.

Yoshihito Ito1, Yukako Nakamura, Nagahide Takahashi, Shinichi Saito, Branko Aleksic, Nakao Iwata, Toshiya Inada, Norio Ozaki.   

Abstract

The FXYD domain containing ion transport regulator 6 (FXYD6) gene is located within a region of chromosome 11 (11q23.3) that has been shown by a number of genome scans to be one of the most well-established linkages to schizophrenia. FXYD6 encodes the protein phosphohippolin, which is primarily expressed in the brain. Phosphohippolin modulates the kinetic activity of Na,K-ATPase and has long-term physiological importance in maintaining cation homeostasis. A recent study reported that FXYD6 was associated with schizophrenia in the United Kingdom samples. Applying the gene-based association concept, we carried out an association study regarding FXYD6 and schizophrenia in a Japanese population, with a sample consisting of 2026 subjects (906 schizophrenics and 1120 controls). After linkage disequilibrium analysis, 23 single nucleotide polymorphisms (SNPs) were genotyped using 5'-exonuclease allelic discrimination assay. We found a significant association of two SNPs (rs11216573; genotypic P value: 0.022 and rs555577; genotypic P value: 0.026, allelic P value: 0.011, uncorrected). Nominal P values did not survive correction for multiple testing (rs11216573; genotypic P value: 0.47 and rs555577; genotypic P value: 0.55, allelic P value: 0.24, after SNPSpD correction). No association was observed between schizophrenia patients and controls in allelic, genotypic and haplotypic analyses. Our findings suggest that FXYD6 is unlikely to be related to the development of schizophrenia in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455306     DOI: 10.1016/j.neulet.2008.04.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  FXYD6 is a new biomarker of cholangiocarcinoma.

Authors:  Xiongfei Chen; Mingzhu Sun; Yazhuo Hu; Honghong Zhang; Zhanbo Wang; Ningxin Zhou; Xinyun Yan
Journal:  Oncol Lett       Date:  2013-12-04       Impact factor: 2.967

2.  FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis.

Authors:  Xiongfei Chen; Lishuang Ding; Deshuai Kong; Xiulei Zhao; Lili Liao; Yaomin Zhang; Fengshan Li; Ruhai Liu
Journal:  Open Life Sci       Date:  2020-04-20       Impact factor: 0.938

3.  Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population.

Authors:  Fuquan Zhang; Yong Xu; Pozi Liu; Hua Fan; Xuezhu Huang; Gaoxiang Sun; Yuqing Song; Pak C Sham
Journal:  BMC Med Genet       Date:  2008-12-30       Impact factor: 2.103

4.  Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.

Authors:  Boris Chaumette; Vladimir Ferrafiat; Amirthagowri Ambalavanan; Alice Goldenberg; Alexandre Dionne-Laporte; Dan Spiegelman; Patrick A Dion; Priscille Gerardin; Claudine Laurent; David Cohen; Judith Rapoport; Guy A Rouleau
Journal:  Mol Psychiatry       Date:  2018-06-12       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.